Cargando…
Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113240/ https://www.ncbi.nlm.nih.gov/pubmed/32238805 http://dx.doi.org/10.1038/s41467-020-15531-2 |
| _version_ | 1783513629150150656 |
|---|---|
| author | Lauss, Martin Donia, Marco Harbst, Katja Andersen, Rikke Mitra, Shamik Rosengren, Frida Salim, Maryem Vallon-Christersson, Johan Törngren, Therese Kvist, Anders Ringnér, Markus Svane, Inge Marie Jönsson, Göran |
| author_facet | Lauss, Martin Donia, Marco Harbst, Katja Andersen, Rikke Mitra, Shamik Rosengren, Frida Salim, Maryem Vallon-Christersson, Johan Törngren, Therese Kvist, Anders Ringnér, Markus Svane, Inge Marie Jönsson, Göran |
| author_sort | Lauss, Martin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7113240 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71132402020-04-03 Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma Lauss, Martin Donia, Marco Harbst, Katja Andersen, Rikke Mitra, Shamik Rosengren, Frida Salim, Maryem Vallon-Christersson, Johan Törngren, Therese Kvist, Anders Ringnér, Markus Svane, Inge Marie Jönsson, Göran Nat Commun Author Correction Nature Publishing Group UK 2020-04-01 /pmc/articles/PMC7113240/ /pubmed/32238805 http://dx.doi.org/10.1038/s41467-020-15531-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Author Correction Lauss, Martin Donia, Marco Harbst, Katja Andersen, Rikke Mitra, Shamik Rosengren, Frida Salim, Maryem Vallon-Christersson, Johan Törngren, Therese Kvist, Anders Ringnér, Markus Svane, Inge Marie Jönsson, Göran Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma |
| title | Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma |
| title_full | Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma |
| title_fullStr | Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma |
| title_full_unstemmed | Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma |
| title_short | Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma |
| title_sort | author correction: mutational and putative neoantigen load predict clinical benefit of adoptive t cell therapy in melanoma |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113240/ https://www.ncbi.nlm.nih.gov/pubmed/32238805 http://dx.doi.org/10.1038/s41467-020-15531-2 |
| work_keys_str_mv | AT laussmartin authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma AT doniamarco authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma AT harbstkatja authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma AT andersenrikke authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma AT mitrashamik authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma AT rosengrenfrida authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma AT salimmaryem authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma AT vallonchristerssonjohan authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma AT torngrentherese authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma AT kvistanders authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma AT ringnermarkus authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma AT svaneingemarie authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma AT jonssongoran authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma |